Hologic’s HOLX Skeletal Health division has been driving positive contributions ever since the earlier supply challenges began to ease. Sales jumped 62.1% in the third quarter of fiscal 2025, driven ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...

Medical technology company Hologic (NASDAQ:HOLX) announced in Q3 CY2025, with sales up 6.2% year on year to $1.05 billion. Its non-GAAP profit of $1.13 per share was 2.7% above analysts’ consensus ...